Nest.Bio
Overview
Nest.Bio is a life-science venture creation and investment firm that provides flexible lab and office space while funding and commercializing early-stage biotechnology startups.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Senti Biosciences | Jan 2021 | Series B | Co-investor |
| Engine Biosciences | May 2021 | Series A | Co-investor |
| Bota Biosciences | - | Seed | Co-investor |
| Foreseen Biotechnology | - | Accelerator | Co-investor |
| M20 Genomics | Apr 2022 | Early Funding | Co-investor |
For institutional investors. Book with your work email.
Key People
Jeffrey Lu
Partner
Alex Wayman
Investor
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Nest.Bio based?
Nest.Bio is headquartered in Somerville, Massachusetts, United States.
When was Nest.Bio founded?
Nest.Bio was founded in 2018.
How many portfolio companies does Nest.Bio have?
Nest.Bio has 14 portfolio companies in Caplight's dataset.
What are some companies in Nest.Bio's portfolio?
Portfolio companies visible on Caplight include Senti Biosciences, Engine Biosciences, Bota Biosciences, Foreseen Biotechnology, M20 Genomics.
What was Nest.Bio's most recent investment shown here?
Nest.Bio's most recent investment in this portfolio sample was in M20 Genomics in 2022.
What sectors does Nest.Bio focus on?
Nest.Bio focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Frontier & Industrial Tech, Frontier & Industrial Tech, Enterprise Software, Enterprise Software.
What company stages does Nest.Bio focus on?
Nest.Bio typically invests at the Early stage.
What is Nest.Bio's AUM?
Nest.Bio's assets under management are estimated between $0.0 and $50.0M.